A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...

The developer in 2024 knows the feeling: an AI assistant suggests a clever-looking function, but wiring it into a real system still takes most of the afternoon. The tools autocomplete and explain, yet ...

The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...

How an excessive focus on methods has distracted attention from the more fundamental challenge of building rigor and learning ...

Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of ...

Real-world data (RWD) and real-world evidence (RWE) are reshaping clinical trials by identifying the patients most likely to benefit from new treatments, allowing sponsors to design studies that are ...

Leading vaccine researchers say that the proposed vaccine trials could lead to unreliable conclusions on already-approved ...

The company is advancing TG4050 in head and neck cancer and possibly to other tumor types based on encouraging Phase I data.

A novel collaboration may establish a framework to help researchers overcome regulatory barriers they often face when ...

The benefits of exercise are limited, disappear if discontinued, and should be an adjunct to talk or drug therapy.